TransEnterix’s New Robotically-Assisted Surgical Device Is Approved by U.S. FDA TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, announced the Company has received FDA 510(k) clearance for the Senhance™ Surgical Robotic System. “The clearance of the Senhance System in the US [..]
Another Revolutionary Gene Therapy Treatment Approved by U.S. FDA Kite, a Gilead Company, (Nasdaq: GILD) announced that the U.S. Food and Drug Administration (FDA) has granted regular approval to Yescarta™ (axicabtagene ciloleucel), the first chimeric antigen receptor T cell (CAR T) therapy for the treatment of adult patients with relapsed or refractory large B-cell [..]
Traffic & Conversions Summit: 2018 March 10th to 12th, 2018 San Diego, CA Every year, thousands of the worlds smartest marketers descend on San Diego, California to learn what’s new, what’s hot, and what’s actually working RIGHT NOW in digital marketing. Here’s what you can [..]
Future of Energy: Cleaner Fossil Fuels By: MARK SHWARTZ | Stanford News This story is part of a series on Stanford collaborations helping to create the Future of Energy. In the United States, most electricity from the grid comes from power plants that run on coal or natural gas. These plants [..]
Future of Energy: Efficiency By: AMY ADAMS | Stanford News In the past few decades, improvements in energy efficiency in our homes, buildings and cars have significantly reduced carbon emissions by cutting demand. In addition to the environmental impacts, this enhanced efficiency has improved national security, reducing energy imports four [..]
New Sodium Based Battery Are More Cost-Effective Storage Than Lithium By: TOM ABATE | Stanford News As a warming world moves from fossil fuels toward renewable solar and wind energy, industrial forecasts predict an insatiable need for battery farms to store power and provide electricity when the sky is dark [..]
This is Why Researchers Should Step Out of The Lab By: David L. Chandler | MIT News Office When Shreya Dave was an MIT doctoral student working on a new kind of filter for desalination plants, she paid a visit to a working reverse-osmosis desalination plant in Spain. She quickly learned [..]
New Form of Data Storage: MIT Research By: David Chandler | MIT News Office New research has shown that an exotic kind of magnetic behavior discovered just a few years ago holds great promise as a way of storing data — one that could overcome fundamental limits that might otherwise be [..]
FDA Approved Roche’s cobas Zika: First Donor Screening Test for Zika Virus By: Roche Molecular Systems, Inc. News Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it has received approval from the U.S. Food and Drug Administration (FDA) for the cobas® Zika test for use on the cobas 6800/8800 Systems. The cobas [..]
FDA Approved Respicardia’s Implantable Device to Treat Central Sleep Apnea By: FDA News The U.S. Food and Drug Administration approved a new treatment option for patients who have been diagnosed with moderate to severe central sleep apnea. The Remedē System is an implantable device that stimulates a nerve located in [..]
FDA Awards 15 Grants for Clinical Trials for The Product Development Against Rare Diseases By: FDA News The U.S. Food and Drug Administration announced that it has awarded 15 new clinical trial research grants totaling more than $22 million over the next four years to boost the development of products [..]
No More Finger Sticks: FDA Approved Abbott’s FreeStyle Libre Flash Glucose Monitoring System By: ASweetLife News The U.S. FDA has approved Abbott’s FreeStyle Libre Flash Glucose Monitoring System as a replacement for blood glucose monitoring (BGM) for adults with diabetes. This revolutionary new glucose sensing technology eliminates the need for routine finger sticks and is the only [..]
FDA Approved Verzenio of Eli Lilly for Certain Advanced or Metastatic Breast Cancers By: FDA News The U.S. Food and Drug Administration approved Verzenio (abemaciclib) to treat adult patients who have hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer that has progressed after taking [..]
SciGlo: A One-Stop Solution for Your Scientific and Career Needs By: Sandhya Sriram Ph.D. | Founder and C.E.O. of SciGlo 26 September 2017 Did you know that more than 65% of students/scientists spend more than 1 hour – 60 minutes! – per day online, searching for information (jobs, internships, products, reagents, labs, [..]
Summit LA17: The World’s Preeminent Ideas Festival November 3-6, 2017 — Downtown Los Angeles About the festival Summit’s 11th flagship, LA17, will gather 3,500 leaders across all disciplines. For three days, the festival will host a diverse array of talks, performances, wellness classes, art installations, gourmet food, and experiences designed [..]
Web Summit MEO ARENA, LISBON, NOVEMBER 6-9, 2017 What is Web Summit? Web Summit started as a simple idea in 2010: Let’s connect the technology community with all industries, both old and new. It seemed to resonate. Web Summit has grown to become the “largest technology conference in the world”. [..]
Rydapt® of Novartis Approved by EU for Acute Myeloid Leukemia (AML) and Systemic Mastocytosis (SM) By : Novartis News Novartis today announced that the European Commission (EC) approved Rydapt® (midostaurin) for two indications in rare, hard-to-treat cancers. Rydapt is approved for use in combination with standard daunorubicin and cytarabine induction and high-dose cytarabine [..]
First Duodenoscope With Disposable Distal Cap Got Clearance by FDA By: FDA News The U.S. Food and Drug Administration cleared the first duodenoscope with a disposable distal cap, a new feature that will improve access for cleaning and reprocessing. The Pentax ED34-i10T model duodenoscope is intended to provide visualization and [..]
Controlling Brain Cancer Growth By Neuroligin-3 Inhibition : Stanford Research By: Erin Digitale | Stanford News The growth of certain aggressive brain tumors can be halted by cutting off their access to a signaling molecule produced by the brain’s nerve cells, according to a new study by researchers at the Stanford University [..]
Bio-Inspired Synthetic RNA Delivery System By: Anne Trafton | MIT News Office By delivering strands of genetic material known as messenger RNA (mRNA) into cells, researchers can induce the cells to produce any protein encoded by the mRNA. This technique holds great potential for administering vaccines or treating diseases such [..]
New FDA Approval to Bayer’s Copanlisib For Adults With Relapsed Follicular Lymphoma By: Bayer News Bayer Healthcare Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved copanlisib under the brand name Aliqopa™ 60 mg vial for injection for the treatment of adult patients with relapsed follicular lymphoma [..]
FDA Approved MVASI™ of Amgen And Allergan : First Biosimilar Treatment for Cancer By: Amgen News Amgen (NASDAQ: AMGN) and Allergan plc. (NYSE: AGN) announced that the U.S. Food and Drug Administration (FDA) has approved MVASI™ (bevacizumab-awwb) for all eligible indications of the reference product, Avastin® (bevacizumab). MVASI is the first anti-cancer biosimilar, as well [..]
50 Life Mantras by Dalai Lama By: Vijay Soni, Ph.D. | Founder and C.E.O. Scipreneur The Dalai Lama, his holiness is a world leader that is committed to promoting positive values such as, forgiveness, self-discipline, tolerance, compassion, and contentment. He is a spiritual leader like no other and is highlighting [..]
FDA Breakthrough Therapy Designation: To Cemiplimab (REGN2810) of Regeneron and Sanofi Source: Regeneron Pharmaceuticals, Inc. News Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation status to cemiplimab (REGN2810) for the treatment of adults with metastatic cutaneous squamous cell carcinoma (CSCC) and adults with locally advanced [..]
The 4th Annual U.Pitch National Elevator Pitch Competition and Showcase November 16, 2017 Future Founders immerses youth in experiences that inspire and empower them to create their own opportunity. We believe this leads to a generation more determined, hopeful and equipped as they engage the future. To date, our programs have [..]
New England Venture Summit: 2017 Where Innovation Meets Capital™ Dec 6th, 2017 Lombardo’s Conference Center, Boston Randolph, MA, USA Early Bird Special Register Now and Save 50% youngStartup‘s Venture Summits connect the most innovative, promising [..]
Eterna: Online Game Challenges To Design On/Off Switch for CRISPR By: Jennie Dusheck | Stanford News A team of researchers at the Stanford University School of Medicine has launched a new challenge for the online computer game Eterna in which players are being asked to design an RNA molecule capable of acting as an on/off [..]
New Solar Cell Inspired By Insect Eyes: Perovskite Based Photovoltaics By: Mark Shwartz | Stanford News Packing tiny solar cells together, like micro-lenses in the compound eye of an insect, could pave the way to a new generation of advanced photovoltaics, say Stanford University scientists. In a new study, the Stanford [..]
Inc.com Women’s Summit This seven-day conference is designed to fully immerse you into the Lean Startup methodology popularized by Eric Ries in his book, The Lean Startup. This event is for you if you’re interested in hacking business models, mastering the lean startup process, and learning from the companies that [..]
Novel Ultrathin Semiconductor Materials By Stanford Engineers By: Andrew Myers | Stanford News The next generation of feature-filled and energy-efficient electronics will require computer chips just a few atoms thick. For all its positive attributes, trusty silicon can’t take us to these ultrathin extremes. Now, electrical engineers at Stanford have [..]
Copyright © 2025 | WordPress Theme by MH Themes